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Objectives The present study aimed to investigate the difference in major adverse cardiac events (MACE) at 12 months in
patients with coronary bifurcation lesions after double kissing double crush (DK crush) or provisional stenting
(PS) techniques.
Background Provisional side branch (SB) stenting is preferable to DK crush because it has been associated with fewer com-
plications. It is unknown which strategy would provide the best results.
Methods From April 2007 to June 2009, 370 unselected patients with coronary bifurcation lesions from 7 Asian centers
were randomly assigned to either the DK or the PS group. Additional SB stenting in PS was required if final re-
sults were suboptimal. The primary end point was the occurrence of MACE at 12 months, including cardiac
death, myocardial infarction, or target vessel revascularization (TVR). Secondary end point was the angiographic
restenosis at 8 months.
Results There were 3 procedural occlusions of SB in the PS group. At 8 months, angiographic restenosis rates in the
main vessel and SB were significantly different between the DK (3.8% and 4.9%) and the PS groups (9.7% and
22.2%, p  0.036 and p  0.001, respectively). Additional SB stenting in the PS group was required in 28.6%
of lesions. TVR was 6.5% in the DK group, occurring significantly less often than in the PS group (14.6%,
p  0.017). There were nonsignificant differences in MACE and definite stent thrombosis between the DK
(10.3% and 2.2%) and PS groups (17.3%, and 0.5%, p  0.070 and p  0.372, respectively).
Conclusions DK crush was associated with a significant reduction of TLR and TVR in this unselected patient population. However,
there was no significant difference in MACE between DK and the PS groups. (Randomized Study on DK Crush
Technique Versus Provisional Stenting Technique for Coronary Artery Bifurcation Lesions; ChicTR-TRC-00000015)
(J Am Coll Cardiol 2011;57:914–20) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.10.023Percutaneous coronary intervention for coronary bifurcation
lesions still remains a hotly debated topic (1). Several studies
(2–4) have concluded that stenting the main vessel (MV)
with provisional stenting (PS) of side branches (SB) is
preferable in the great majority of bifurcation lesions.
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February 22, 2011:914–20 Double Kissing Crush Versus Provisional Stentingto address the clinical relevance of double kissing double
crush (DK crush) and PS in our “unselected” patient
population.
Methods
Patient selection. The DKCRUSH-II study was con-
ucted in 7 Asian centers after the protocol was approved by
he ethics committee, and signed informed consent was
btained from all patients.
Patients18 years of age with a diagnosis of documented
ilent ischemia, angina, or acute myocardial infarction
AMI) (12 h proceeding to an emergent percutaneous
oronary intervention procedure) after the restoration of
lood flow in 2 branches, were considered eligible for
nrollment. Patients with chronic total occlusion in the MV
r SB immediately after successful recanalization, and un-
rotected distal left main bifurcation lesions involving both
stia of the left anterior descending and left circumflex
oronary arteries, without chronic total occlusion in the
ight coronary artery, were also enrolled. An additional
ligibility criterion was the presence of only 1 coronary
ifurcation lesion (Medina [5] classification 1,1,1 and 0,1,1)
er patient, defined as a diameter stenosis of 50% in both
essels with a reference vessel diameter between 2.5 and 4.0
m by visual estimation. The maximum treatable lesion
ength by visual estimation for each individual branch had to
e completely covered by 2 EXCEL stents (JW Medical
ystem, Weihai, China) (6).
Exclusion criteria included liver dysfunction, expected
ifespan 12 months, heavy calcification requiring rota-
ional atherectomy, pregnancy, contraindication, or sus-
ected intolerance to one of the study drugs.
Baseline Clinical CharacteristicsTable 1 Baseline Clinical Characteristics
DK Group
(n  185)
PS Group
(n  185) p Value
Age, yrs 63.9 11.1 64.6 9.9 0.542
Male 146 (78.9) 141 (76.2) 0.618
Diabetes 36 (19.5) 44 (23.8) 0.377
Hypertension 121 (65.4) 112 (60.5) 0.403
Hyperlipidemia 63 (34.1) 53 (28.6) 0.336
Current smoking 57 (30.8) 44 (23.8) 0.315
Serum creatinine 2.5 mg/dl 10 (5.41) 17 (9.19) 0.360
Previous MI 32 (17.3) 26 (14.1) 0.475
Previous PCI 39 (21.1) 38 (20.5) 1.000
Previous CABG 0 (0) 1 (0.5) 0.500
Acute MI 30 (16.2) 31 (16.8) 1.000
ST-segment elevation MI 25 (13.5) 22 (11.9) 0.755
Non–ST-segment elevation MI 5 (2.7) 9 (4.9) 0.415
Unstable angina 123 (66.5) 126 (68.1) 0.557
Stable angina 29 (15.7) 21 (11.4) 0.287
Silent ischemia 3 (0.8) 7 (1.9) 0.296
LVEF 40% 28 (15.1) 21 (11.4) 0.333
Values are mean  SD or n (%).
CABG  coronary artery bypass graft; DK  double kissing; LVEF  left ventricular ejectionfraction; MI  myocardial infarction; PCI  percutaneous coronary intervention; PS  provisional
stenting.Procedure. Patients were ran-
domly assigned in a 1:1 ratio to
the DK crush (DK group) or the
PS group. DK crush, as de-
scribed previously (7), was per-
formed as follows: stenting SB,
balloon crush, first kissing bal-
loon inflation, stenting MV, and
final kissing balloon inflation
(FKBI). Another key step in the
procedure is the alternative infla-
tion with a noncompliant balloon
at high pressure (16 atm) for
the SB before each kissing. In
the PS group, a “safety” wire
prior to MV stent placement was
used in all cases. Criteria for
treatment of SB following MV
stent placement were: diameter
stenosis 50%, dissection type
B, or decreased Thrombolysis
In Myocardial Infarction (TIMI)
flow. If balloon dilation was not
successful, then the T stent tech-
nique was performed, followed
by FKBI. Intravascular ultra-
sound pre-dilation and the ad-
ministration of glycoprotein IIb/
IIIa inhibitors were left to the
operator’s discretion.
All patients were pretreated
with aspirin and clopidogrel. A
300-mg loading dose of clopi-
dogrel was administered before the index procedure if
patients were not pretreated. Intravenous unfractionated
heparin was used to maintain an activated clotting time
between 250 and 300 s through the whole procedure. Total
creatine kinase (CK) and CK-MB were dynamically mea-
sured until 72 h post-procedure. After discharge, aspirin
therapy was continued indefinitely (100 mg/day for life),
and clopidogrel (75 mg/day) was continued for at least 12
months.
Follow-up. Clinical follow-up was performed with visits or
telephone contact at 1, 6, 8, and 12 months. Adverse events
were monitored throughout the entire study period.
Follow-up coronary angiography was scheduled at 8 months
after the indexed procedure unless clinical reasons indicated
earlier.
Quantitative coronary angiographic measurements.
Matched orthogonal views were used for quantitative cor-
onary analysis (QCA) before, post-procedure, and at
follow-up after intracoronary injection of nitroglycerin
(100 to 200 g). Angiograms were analyzed offline with a
validated automated edge-detection coronary bifurcation
system (CAAS version 5.7, Pie Medical Imaging, Maas-
Abbreviations
and Acronyms
AMI  acute myocardial
infarction
DK crush  double kissing
double crush
DS  diameter stenosis
FKBI  final kissing balloon
inflation
ISR  in-stent restenosis
KUS  unsatisfactory
kissing
MACE  major adverse
cardiac events
MI  myocardial infarction
MLD  minimal lumen
diameter
MV  main vessel
POC  polygon of
confluence
PS  provisional stenting
QCA  quantitative
coronary analysis
SB  side branch
ST  stent thrombosis
TIMI  Thrombolysis In
Myocardial Infarction
TLR  target lesion
revascularization
TVR  target vessel
revascularizationtricht, the Netherlands). Vessel segments involving bifurca-
tT
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and SB segments within 5 mm proximal or distal to the
stent, and polygon of confluence (POC). QCA variables
included reference vessel diameter, minimal lumen diameter
(MLD), acute gain, late lumen loss, and net gain. QCA
analysis was performed by an independent core laboratory
(CCRF [China Cardiovascular Research Foundation], Bei-
jing, China).
Study end points and definitions. The primary end point
was the occurrence of major adverse cardiac events (MACE)
at 12 months, included cardiac death, myocardial infarction
(MI), or target vessel revascularization (TVR). The clinical
study end points were analyzed by members of an indepen-
dent committee who were blinded to the treatment alloca-
tion. Secondary angiographic end points were restenosis in
Lesion CharacteristicsTable 2 Lesion Characteristics
DK Group
(n  185)
PS Group
(n  185) p Value
Number of diseased vessels 0.066
1-vessel disease 56 (30.3) 64 (34.6)
2-vessel disease 75 (40.5) 51 (27.6)
3-vessel disease 54 (29.1) 70 (37.8)
Lesion site 0.746
LAD-LCX 33 (17.8) 29 (15.7)
LAD-diagonal 112 (60.5) 110 (59.5)
LCX-obtuse marginal 23 (12.4) 30 (16.2)
Distal right coronary artery 17 (9.2) 16 (8.6)
Medina stratification 0.187
1,1,1 155 (83.8) 144 (77.8)
0,1,1 30 (16.2) 41 (22.2)
Main vessel TIMI flow grade 0.414
02 26 (14.1) 31 (16.8)
3 159 (85.9) 154 (83.2)
Lesions in main vessel
In-stent restenosis 2 (1.1) 5 (2.7) 0.449
Chronic total occlusion 8 (4.3) 16 (8.6) 0.138
Thrombus-containing 10 (5.4) 5 (2.7) 0.292
Severe tortuous 17 (9.2) 20 (10.8) 0.729
Severe calcification 2 (1.1) 5 (2.7) 0.449
Concentric 13 (7.0) 11 (5.9) 0.680
Lesions in side branch
In-stent restenosis 3 (1.6) 5 (2.7) 0.504
Chronic total occlusion 3 (1.6) 3 (1.6) 1.000
Thrombus-containing 6 (3.2) 3 (1.6) 0.332
Severe tortuous 25 (13.5) 31 (16.8) 0.469
Severe calcification 2 (1.1) 5 (2.7) 0.449
Concentric 17 (9.2) 15 (8.1) 0.854
Side branch TIMI flow grade 0.610
02 11 (6.0) 13 (7.1)
3 174 (94.1) 172 (93.0)
Type C lesions
Main vessel 119 (64.3) 126 (68.1) 0.584
Side branch 46 (24.9) 45 (24.3) 0.141
Values are n (%).
LAD  left anterior descending coronary artery; LCX  left circumflex coronary artery; TIMI 
hrombolysis In Myocardial Infarction; other abbreviations as in Table 1.the MV and SB at 8 months. MI was diagnosed if theplasma level of CK-MB increased to1 times the pre-value
immediately before stenting in AMI patients. MI in non-
AMI patients, cardiac death, in-stent restenosis (ISR),
target lesion revascularization (TLR), TVR, angiographic
and procedural success, and stent thrombosis (ST) were
defined according to Nordic criteria (2) and the Academic
Research Consortium (ARC) definitions (9). Unsatisfactory
kissing (KUS) was defined as the difference between vessel/
stent diameter and balloon diameter used for FKBI 0.5
mm or the presence of residual stenosis 20% during FKBI
by visual estimation. Lesion specificities were defined ac-
cording to American Heart Association/American College
of Cardiology criteria (10). Angiographic patterns of ISR
were defined by Mehran’s classification (11) and classified
by Class I to IV.
Statistical analysis. We hypothesized that the rate of
concurrent MACE between the 2 arms would be signifi-
cantly different, favoring the DK crush (  12%) versus
he PS (  24%) approach. A total sample size of 316 was
needed to detect a 50% reduction in the MACE rate (80%
power,   0.05, 2-sided [tailed]). To accommodate a 15%
(n  47) loss and because of considerable uncertainty about
Procedural CharacteristicsTable 3 Procedural Characteristics
DK Group
(n  185)
PS Group
(n  185) p Value
Intravascular ultrasound used 85 (45.9) 88 (47.6) 0.655
Glycoprotein IIb/IIIa inhibitor used 8 (4.3) 2 (1.1) 0.105
Pre-dilation
Main vessel 78 (42.2) 105(56.8) 0.007
Side branch 82 (44.3) 68 (36.8) 0.169
Pre-dilation using KBI 25 (13.5) 16 (8.6) 0.185
No. patients stratified by no. stent
Main vessel 0.475
1 stent 141 (76.2) 142 (76.8)
2 stents 42 (22.7) 38 (20.5)
3 stents 2 (1.1) 5 (2.7)
Side branch 0.001
0 stents 0 (0) 132 (72.4)
1 stent 174 (94.1) 52 (28.1)
2 stents 10 (5.4) 1 (0.5)
3 stents 1 (0.5) 0 (0)
Post-dilation for stents
Main vessel 185 (100.0) 162 (87.6) 0.008
Inflation pressure, atm* 14.43 2.13 14.47 2.25 1.000
Side branch 185 (100.0) 70 (37.8) 0.001
Inflation pressure, atm* 12.21 2.17 12.28 2.15 0.904
Final kissing balloon inflation 185 (100.0) 147 (79.5) 0.001
Unsatisfactory kissing 15 (8.1) 47 (25.4) 0.001
Angiographic success
Main vessel 184 (99.5) 181 (97.8) 0.372
Side branch 185 (100.0) 177 (95.7) 0.007
Complete revascularization 171 (92.4) 176 (95.1) 0.390
Procedural time, min 37.66 20.04 36.59 30.01 0.688
Total fluoroscopy time, min 23.09 18.14 22.48 17.68 0.781
Contrast volume, ml 148.71 88.19 137.46 94.97 0.238Values are n (%) or mean  SD. *Indicates the pressure during final kissing balloon inflation.
KBI  kissing balloon inflation; other abbreviations as in Table 1.
is; RVD
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enrollment to 370 patients. The treatment-group differ-
ences were evaluated with analysis of variance or Wilcoxon
rank sum scores for continuous variables. When ordinal
tests were required for continuous variables, medians and
quartiles were used as the descriptive statistics. The chi-
square test or the Fisher exact test was used to analyze
categorical variables. Survival rate free from events was
generated by Kaplan-Meier analysis. Statistical significance
was taken as a 2-sided p value 0.05. All analyses were
performed with the use of the statistical program SPSS 16.0
(SPSS Institute Inc, Chicago, Illinois).
Results
Baseline characteristics. From April 17, 2007, to June 23,
2009, 370 patients (average age 64.32  10.46 years) with
true bifurcation lesions were enrolled and randomly assigned
to the DK (n  185) and PS (n  185) groups. Baseline
clinical and lesion characteristics (including the number of
diseased vessels, lesion location, stratification of lesions, and
TIMI flow grade 0 to 2) were well matched between the 2
groups (Tables 1 and 2).
Procedural characteristics. In the PS group, 121 (65.4%)
SB received balloon angioplasty only, 11 (5.9%) SB did not
receive any therapy, and in 53 (28.6%) SB, additional stents
were required. A significant reduction in angiographic
success was observed in the SB between the DK and PS
groups (p  0.007) (Table 3). The procedural time, total
fluoroscopy, and contrast volume in the DK group were
nonsignificant compared with the PS group. KUS was more
frequently in PS (25.4%) group, compared with 8.1% in DK
QCA in Entire Cohort of PatientsTable 4 QCA in Entire Cohort of Patients
Main Vessel
DK (n  185) PS (n  185)
Pre-procedure
RVD, mm 2.86 0.31 2.82 0.37
MLD, mm 0.94 0.35 0.86 0.36
DS, % 67.2 14.5 69.5 16.9
Lesion length, mm 28.4 12.9 28.7 15.5
Post-procedure
RVD, mm 2.97 0.44 2.89 0.41
MLD, mm 2.72 0.51 2.58 0.44
DS, % 9.7 3.7 11.9 6.3
Acute gain, mm 1.59 0.49 1.56 0.56
At 8-month follow-up
RVD, mm 2.98 0.42 2.91 0.47
MLD, mm 2.47 0.56 2.35 0.55
DS, mm 17.3 10.5 20.6 12.1
Late loss, mm 0.10 0.43 0.09 0.47
Net gain, mm 1.48 0.55 1.37 0.64
Restenosis 7 (3.8) 18 (9.7)
Values are mean  SD or n (%).
DS  diameter stenosis; MLD  minimal lumen diameter; QCA  quantitative coronary analysgroup (p  0.001).QCA analysis. Repeat angiogram at 8 months (average
249.51  52.41 days) was available in 339 (91.6%) patients.
There were no significant differences in terms of the
baseline characteristics between the 2 groups (Table 4). DK
crush was associated with increased post-stenting MLD in
the MV, POC, and SB (Tables 4 and 5). This resulted in a
significant reduction of diameter stenosis (DS), an increase
in acute gain, and an increased net gain in POC and SB
relative to the PS group, with the exception of the MV.
The overall restenosis rates in the MV and SB were 3.8%
and 4.9% in the DK group, respectively, compared with
9.7% (p  0.036) and 22.2% (p  0.001) in the PS group.
Side Branch
Value DK (n  185) PS (n 185) p Value
0.555 2.38 0.32 2.29 0.35 0.329
0.264 0.89 0.30 0.84 0.30 0.413
0.436 62.8 14.7 63.4 14.2 0.762
0.884 15.4 11.3 14.9 12.5 0.842
0.226 2.49 0.38 2.36 0.35 0.036
0.036 2.18 0.43 1.63 0.46 0.003
0.485 12.3 8.6 28.6 13.8 0.027
0.365 1.48 0.51 0.99 0.51 0.048
0.976 2.43 0.35 2.38 0.36 0.010
0.746 1.85 0.47 1.43 0.53 0.002
0.907 22.9 13.0 32.2 18.6 0.011
0.809 0.22 0.41 0.18 0.45 0.496
0.675 1.37 0.59 0.87 0.63 0.019
0.036 9 (4.9) 4 1 (22.2) 0.001
 reference vessel diameter; other abbreviations as in Table 1.
Quantitative Coronary Analysis for POC AreaTable 5 Quantitative Coronary Analysis for POC Area
DK Group
(n  185)
PS Group
(n  185) p Value
Pre-procedure
RVD, mm 2.72 0.49 2.70 0.50 0.162
MLD, mm 0.86 0.38 0.83 0.35 0.692
DS, % 67.3 11.5 69.3 13.5 0.576
Post-procedure
RVD, mm 2.85 031 2.78 0.30 0.754
MLD, mm 2.12 0.36 1.98 0.38 0.003
DS, % 20.0 14.5 23.2 12.7 0.235
Acute gain, mm 1.18 0.44 1.14 0.48 0.309
At 8 months
RVD, mm 2.67 0.40 2.68 0.51 0.962
MLD, mm 2.07 0.56 1.87 0.55 0.001
DS, % 22.5 14.5 30.2 17.4 0.003
Late loss, mm 0.06 0.48 0.12 0.50 0.023
Net gain, mm 1.13 0.52 1.02 0.54 0.007
Restenosis 8 (4.3) 36 (19.5) 0.001pValues are mean  SD or n (%).
Abbreviations as in Tables 1 and 4.
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groups were as follows: 18.4% versus 3.8% (p  0.001), and
19.5% versus 4.3% (p  0.001). Class I ISR in MV and SB
were seen in 82% and 88%, with Class II, III, and IV in 11%
and 6%, 3% and 2%, and 4% and 4%, respectively. The
presence of KUS predicted the occurrence of ISR in MV
(hazard ratio [HR]: 4.007, 95% confidence interval [CI]:
1.640 to 10.110, p  0.025) and SB (HR: 0.491, 95% CI:
0.243 to 0.991, p  0.037).
Clinical outcome. SB occlusion immediately after MV
stent placement occurred 3 times (1.6%) in the PS group
(Table 6). There were no significant differences in proce-
dural success rate and cumulative MACE and ST rate at 6
months between the 2 groups (Table 6).
At 12 months, the rates of cardiac death and MI in the
DK and PS groups were comparable. TLR in the DK group
(4.3%) occurred significantly less often than in the PS group
Clinical OutcomeTable 6 Clinical Outcome
DK Group
(n  185)
PS Group
(n 185) p Value
Intra-procedural
Acute closure 0 (0) 3 (1.6) 0.248
Cardiac death 0 (0) 0 (0) 1.000
Emergent CABG 0 (0) 0 (0) 1.000
Needing IABP 0 (0) 0 (0) 1.000
MI 0 (0) 3 (1.6) 0.248
In-hospital
Cardiac death 1 (0.5) 0 (0) 0.500
MI 6 (3.2) 4 (2.2) 0.751
CABG 0 (0) 0 (0) 1.000
TLR 1 (0.5) 1 (0.5) 1.000
TVR 1 (0.5) 1 (0.5) 1.000
MACE 6 (3.2) 4 (2.2) 0.751
Stent thrombosis definite 4 (2.2) 1 (0.5) 0.372
Procedural success 179 (96.8) 173 (93.5) 0.217
At 6-month
Cardiac death 1 (0.5) 2 (1.1) 1.000
MI 6 (3.2) 4 (2.2) 0.751
CABG 0 (0) 1 (0.5) 0.500
TLR 2 (1.1) 6 (3.2) 0.284
TVR 3 (1.6) 8 (4.3) 0.220
MACE 6 (3.2) 11 (5.9) 0.321
Stent thrombosis definite 4 (2.2) 1 (0.5) 0.372
At 12-month
Cardiac death 2 (1.1) 2 (1.1) 1.000
MI 6 (3.2) 4 (2.2) 0.751
CABG 0 (0) 1 (0.5) 0.500
TLR 8 (4.3) 24 (13.0) 0.005
TVR 12 (6.5) 27 (14.6) 0.017
MACE 19 (10.3) 32 (17.3) 0.070
Stent thrombosis 5 (2.7) 2 (1.1) 0.449
Definite 4 (2.2) 1 (0.5) 0.372
Possible 1 (0.5) 1 (0.5) 1.000
Values are n (%).
IABP  intra-aortic balloon pumping; MACE  major adverse cardiac event(s); TLR  target
esion revascularization; TVR  target vessel revascularization; other abbreviations as in Table 1.(13.0%, p  0.005) (Fig. 1A), with clinically driven TLR inFigure 1 Comparison of Survival Rate Free From TLR,
TVR, and MACE Between DK Crush and PS Groups
(A) Target lesion revascularization (TLR), (B) target vessel revascularization
(TVR), and (C) major adverse cardiac events (MACE). PS  provisional
stenting.
travasc
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TLR in 3 (1 in the DK and 2 in PS groups) patients. This
translated into an increased rate of TVR in the PS group
(14.6% vs. 6.5%, p  0.017) (Fig. 1B). However, there was
no difference in the cumulative MACE between the DK
(10.3%) versus PS (17.3%, p  0.070) groups (Fig. 1C).
The overall and definite ST in DK were 2.7% and 2.2%, all
nonsignificant with respect to PS group (1.1% and 0.5%,
respectively). The timing, baseline, and procedural charac-
teristics of patients in whom ST occurred are summarized in
Table 7.
Discussion
The major findings of the present study were: 1) 28.6% of
patients in the PS group were transferred to the 2-stent
subgroup; and 2) DK crush had a lower rate of TLR and
TVR at 12 months in this unselected patient population,
with 91.6% having repeat angiograms at 8 months.
Comparison with previous studies. The rate of PS with
SB stenting varied mainly depending on the study design.
When stenting of the SB was limited to the cases with
severely impaired blood flow (2,12), this rate was around
2% to 4%. If residual stenosis 50% was considered as
one of the criteria, stenting the SB was required in 22%
(13) and 31.3% of cases (4), respectively, similar to our
results (28.6%). By PS, acute closure of the SB might be
life threatening or could result in MI, as occurred in 1.6%
of patients in the DKCRUSH-II and in 1.14% of
patients in CACTUS (Coronary Bifurcations: Applica-
tion of the Crushing Technique Using Sirolimus-Eluting
Stents) (1.14%) studies (4). On the other hand, smaller
SB did not result in any significant clinical events even if
they were occluded, as occurred in the BBC ONE (BBC
ONE–British Bifurcation Coronary Study) and Nordic
Patients With STTable 7 Patients With ST
1 (PS) 2 (DK) 3
ARC definition Definite Definite D
Days from PCI 17 5
Location of ST MV SB
DPT Yes Yes
No. of stents 3/1 2/1
Stent length, mm 123 84
Diabetes Yes Yes
Diseased vessels 3 2
Lesion location LAD-LCX LAD-D L
Calcification Yes No
IVUS used Yes No
FKBI Yes Yes
Inflation pressure during FKBI, atm 14 10 14 10 8
Clinical consequence QMI  TLR QMI  TLR QM
D  diagonal; DPT  dual antiplatelet therapy; FKBI  final kissing balloon inflation; IVUS  in
yocardial infarction; SB  side branch; ST  stent thrombosis; other abbreviations as in Tablesstudy (2,3). The lack of any angiographic core laboratoryevaluation, 26% lesions not defined as true bifurcation
lesions, and no study monitoring would likely result in
underreporting of MACE. Therefore, results from those
highly selected patients could not guide our everyday
clinical practices.
Differences between DK, classical crush, and PS. Studies
comparing a complex versus a simple approach for bifurca-
tion lesions have studied different 2-stent techniques
(2,12,14–16). Of these techniques, classical crush was
extensively accepted at its early stage. The performance of
FKBI is a crucial step in reducing restenosis, ST, and
MACE (17–19). The quality of FKBI should not be
ignored when crush stenting was used. Conceptually, clas-
sical crush with 2-step kissing is easily confused with DK
crush. The former method introduces the first kissing
inflation by the MV balloon and side stent without rewiring
the SB, resulting in no real difference from the original
crush. DK crush, focusing on the performance and quality
of each kissing inflation using a noncompliant balloon in the
SB, was associated with a significant reduction of TVR in
the MV and SB (19,20).
On the other hand, the routine use of FKBI after the
1-stent technique for simple bifurcations would not carry
any advantage over that without FKBI (21), but without
functional assessment (22). The present study reported a
2.6-fold increase of ISR in MV by PS, which might reflect
the importance of the quality of FKBI even after the 1-stent
technique.
Comparison of safety end points. The 2-stent technique
seems also to have a detrimental impact on the occurrence of
ST (1,4,10,23), varying from 0.2% to 4.5%. However, the
presence of procedural SB occlusion in the PS group in the
DKCRUSH-II and CACTUS studies indicated that a
jailed wire in the SB could not improve the procedural safety
Patient (Technique)
4 (DK) 5 (DK) 6 (PS) 7 (DK)
Definite Definite Possible Possible
2 6 182 205
SB SB Unknown Unknown
Yes Yes Yes No stopped on day 195
1/1 1/1 1/1 1/1
60 50 66 36
No No No No
2 2 3 3
LAD-LCX LAD-D LAD-LCX LAD-LCX
No Yes Yes Yes
Yes No Yes Yes
Yes Yes Yes Yes
14 14 14 14 16 16 12 12
QMI  TLR Death NQMI Death
ular ultrasound; MV  main vessel; NQMI  non–Q-wave myocardial infarction; QMI  Q-wave
nd 6.(DK)
efinite
1
MV
Yes
1/1
46
No
2
AD-D
Yes
Yes
Yes
 8
I  TLRin bigger SB with a heavy plaque burden.
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crush stenting would be superior to PS for complex/high-
risk bifurcation lesions.
Study limitations. The present study reported clinical
results at 12 months. We could not address the difference in
clinical outcome when follow-up was extended. Another
limitation is the lack of functional assessment by fractional
flow reserve. Finally, sample sizes were probably inadequate
for the analysis of ST risk in 2 groups.
Conclusions
This DKCRUSH-II study for unselected patients with
coronary bifurcation lesions indicates that implantation of
sirolimus-eluting stents was associated with a lower rate of
overall restenosis in the MV. DK crush reduced the occur-
rence of restenosis in both the MV and SB, resulting in a
reduction of TLR and TVR.
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